Date published: 2026-5-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

NPT1 Inhibitors

NPT1 inhibitors belong to a distinctive chemical class primarily characterized by their ability to modulate the activity of the sodium-dependent phosphate transporter 1 (NPT1). This transporter, encoded by the SLC17A1 gene, plays a crucial role in regulating phosphate homeostasis within the body by facilitating the cellular uptake of inorganic phosphate. The chemical structure of NPT1 inhibitors is diverse, with a variety of compounds falling under this class. These inhibitors typically interfere with the normal function of NPT1 by binding to specific sites on the transporter protein, thereby impeding its ability to transport phosphate ions across cellular membranes.

NPT1 inhibitors hinges on their capacity to disrupt the delicate balance of phosphate absorption and excretion, which is vital for various physiological processes, including bone mineralization, cellular energy metabolism, and intracellular signaling. By selectively targeting NPT1, these inhibitors offer a means to manipulate phosphate transport dynamics, potentially influencing cellular phosphate levels. The development of NPT1 inhibitors has gained attention due to their potential impact on phosphate-related disorders. Understanding the intricate mechanisms by which these inhibitors modulate phosphate transport may shed light on novel avenues for research and development in the future. Despite ongoing investigations, the comprehensive characterization of NPT1 inhibitors and their broader implications in cellular physiology remains an active area of scientific inquiry.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Probenecid

57-66-9sc-202773
sc-202773A
sc-202773B
sc-202773C
1 g
5 g
25 g
100 g
$28.00
$39.00
$100.00
$277.00
28
(2)

Competitively inhibits various anion transporters, potentially reducing the function of SLC17 family members.

Suramin sodium

129-46-4sc-507209
sc-507209F
sc-507209A
sc-507209B
sc-507209C
sc-507209D
sc-507209E
50 mg
100 mg
250 mg
1 g
10 g
25 g
50 g
$152.00
$214.00
$728.00
$2601.00
$10965.00
$21838.00
$41096.00
5
(1)

Non-selectively inhibits various membrane proteins, possibly altering SLC17A1-related transport.

Indomethacin

53-86-1sc-200503
sc-200503A
1 g
5 g
$29.00
$38.00
18
(1)

Inhibits anion transporters indirectly by affecting prostaglandin synthesis, altering renal transport dynamics.

5-Nitro-2-(3-phenylpropylamino)benzoic Acid (NPPB)

107254-86-4sc-201542
sc-201542B
sc-201542A
10 mg
25 mg
50 mg
$109.00
$193.00
$317.00
7
(1)

Blocks various chloride channels and anion transporters, potentially affecting SLC17A1.

Furosemide

54-31-9sc-203961
50 mg
$41.00
(1)

A loop diuretic that inhibits the NKCC2, can have secondary effects on phosphate transport.

Bumetanide (Ro 10-6338)

28395-03-1sc-200727
sc-200727A
1 g
5 g
$109.00
$228.00
9
(1)

Similar to Furosemide, inhibits NKCC2 which could indirectly influence SLC17A1 activity.

Lithium

7439-93-2sc-252954
50 g
$214.00
(0)

Affects inositol monophosphatase leading to changes in anion transport, could alter SLC17A1 function.

Clofibrate

637-07-0sc-200721
1 g
$33.00
(1)

Alters lipid metabolism and can influence membrane transporters by modifying membrane properties.

Hydrochlorothiazide

58-93-5sc-207738
sc-207738A
sc-207738B
sc-207738C
sc-207738D
5 g
25 g
50 g
100 g
250 g
$55.00
$240.00
$333.00
$562.00
$988.00
(0)

A thiazide diuretic that affects electrolyte reabsorption, could indirectly affect SLC17A1-related transport.

Chlorothiazide

58-94-6sc-202536
sc-202536A
sc-202536B
1 g
5 g
10 g
$39.00
$107.00
$175.00
(0)

Similar to Hydrochlorothiazide, could have an indirect effect on SLC17A1 activity by altering ion balance.